Alex Pasteur, PhD, is a Partner at F-Prime Capital based in London who joined the firm in 2012 after working. See sector focus and contact routes.
Alex Pasteur, PhD, is a Partner at F-Prime Capital based in London who joined the firm in 2012 after working in healthcare investing since 2001, including at MVM Life Science Partners. He focuses his investment thesis on therapeutics and life sciences, with specific interest in biotech, data-driven life sciences, and healthcare IT. While his typical check size and lead/follow behavior are not publicly specified, he served as a founding investor in ARTBIO, Tenpoint Therapeutics, and Orchard Therapeutics, which was acquired by Kyowa Kirin. Notable portfolio companies in his track record include Orchard Therapeutics, Acacia Pharma (acquired by Eagle Pharmaceuticals), ARTBIO, and Tenpoint Therapeutics. Pasteur currently serves on the boards of Nodthera, Genomics Ltd, Peptone Ltd, Shift Bioscience Ltd, Owkin, and Pulmocide Ltd, and is an observer for Castor. His distinctive background includes a PhD in Chemistry and an MA in Natural Sciences from Cambridge University, which informs his expertise in the biotech sector. No public writing or distinctive point-of-view articles by Pasteur are identified in the available sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in London.
Investors like Alex Pasteur · Full investor directory · Investor access · Company funding database